FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab

Overview of attention for article published in Frontiers in immunology, July 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,351 followers.

RT @FrontImmunol: New Research: FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab: Introduction Targeti…

28 Jul 2023

Reply Repost Favourite

New Research: FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab: Introduction Targeting costimulatory receptors of the tumor necrosis factor receptor (TNFR) superfamily with agonistic antibodies is a… #immunology https:/

28 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.